Banque Cantonale Vaudoise’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,042	Closed	-$23K	–	1062
2023 Q4	$23K	Sell	1,042 -247	-19%	-$4.89K	﹤0.01%	886
2023 Q3	$27K	Sell	1,289 -33	-2%	-$953	﹤0.01%	1034
2023 Q2	$62K	Hold	1,322	–	–	﹤0.01%	942
2023 Q1	$55K	Hold	1,322	–	–	﹤0.01%	944
2022 Q4	$50K	Hold	1,322	–	–	﹤0.01%	956
2022 Q3	$52K	Sell	1,322 -27	-2%	-$1.04K	﹤0.01%	983
2022 Q2	$44K	Sell	1,349 -720	-35%	-$24.1K	﹤0.01%	1027
2022 Q1	$68K	Sell	2,069 -2,439	-54%	-$91.7K	﹤0.01%	987
2021 Q4	$192K	Sell	4,508 -275	-6%	-$11.5K	0.01%	841
2021 Q3	$212K	Buy	4,783 +272	+6%	+$12.5K	0.01%	786
2021 Q2	$256K	Buy	4,511 +429	+11%	+$30.3K	0.01%	786
2021 Q1	$306K	Sell	4,082 -81	-2%	-$6.64K	0.02%	670
2020 Q4	$360K	Sell	4,163 -3,591	-46%	-$265K	0.02%	583
2020 Q3	$474K	Buy	7,754 +450	+6%	+$22.8K	0.03%	448
2020 Q2	$304K	Sell	7,304 -137	-2%	-$4.97K	0.02%	539
2020 Q1	$214K	Buy	7,441 +4,618	+164%	+$267K	0.02%	606
2019 Q4	$204K	Buy	+2,823	New	+$347K	0.01%	718